F

Flower One Holdings Inc
CNSX:FONE

Watchlist Manager
Flower One Holdings Inc
CNSX:FONE
Watchlist
Price: 0.005 CAD Market Closed
Market Cap: 2.3m CAD

Relative Value

There is not enough data to reliably calculate the relative value of FONE.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FONE Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.7
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.1
Industry
21.6
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.2
Industry
16.9
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
22.9
vs History
vs Industry
Median 3Y
-0.1
Median 5Y
-0.1
Industry
2.3
vs History
vs Industry
Median 3Y
2.4
Median 5Y
2.4
Industry
3
vs History
vs Industry
Median 3Y
6.2
Median 5Y
6.2
Industry
5.6
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-12.2
Industry
13.4
vs History
vs Industry
Median 3Y
-6.6
Median 5Y
-6.6
Industry
16.7
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-10.4
Industry
16.1
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-9.3
Industry
18.9
vs History
vs Industry
Median 3Y
1.1
Median 5Y
1.1
Industry
2

Multiples Across Competitors

FONE Competitors Multiples
Flower One Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Flower One Holdings Inc
CNSX:FONE
2.4m CAD 0 -0.1 -12.2 -6.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
504.6B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
272.7B CHF 4.4 28.9 12.3 14.4
UK
AstraZeneca PLC
LSE:AZN
219B GBP 5.1 31.4 109.4 160.1
US
Merck & Co Inc
NYSE:MRK
271.6B USD 4.2 14.3 10.1 12
CH
Novartis AG
SIX:NOVN
218.4B CHF 4.9 19 12 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.3 16.2 11.3 13.1
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
CA
F
Flower One Holdings Inc
CNSX:FONE
Average P/E: 25
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.9
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.4
37%
0.8
US
Merck & Co Inc
NYSE:MRK
14.3
15%
1
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.2
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
F
Flower One Holdings Inc
CNSX:FONE
Average EV/EBITDA: 440.1
Negative Multiple: -12.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.3
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
109.4
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
F
Flower One Holdings Inc
CNSX:FONE
Average EV/EBIT: 1 883.8
Negative Multiple: -6.6
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.4
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
160.1
23%
7
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5